SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
SmartKem disclosed multiple unregistered private placements of convertible preferred stock and warrants totaling approximately $7.0 million in proceeds across four closings (March 30, June 22, July 16, and July 24, 2026), issued under Section 4(a)(2) and Regulation D exemptions with significant dilution potential.
View raw filing on EDGAR →C3is Inc. announced the pricing of an underwritten public offering of 11,535,000 units at $0.52 per unit, generating approximately $6.0 million in gross proceeds. Each unit includes one common share (or pre-funded warrant) and one Class F warrant, with the warrants featuring a zero cash exercise option that could double the number of shares issuable. This is a material dilutive equity issuance that would significantly affect a reasonable investor's assessment of ownership dilution and capital structure.
View raw filing on EDGAR →Codexis completed a public offering of 16,666,667 shares of common stock at $1.50 per share, raising approximately $23.1 million in net proceeds. This is a material dilutive equity issuance disclosed under Item 8.01, representing a significant capital raise and shareholder dilution event that would affect a reasonable investor's assessment of the company's capitalization and ownership structure.
View raw filing on EDGAR →Apollo Infrastructure Company LLC issued and sold approximately $42.3 million in unregistered equity securities across multiple share classes (Series I and Series II A-II, E, F-I, and I Shares) to third-party investors as of July 1, 2026, under Section 4(a)(2) and Regulations D and S exemptions.
View raw filing on EDGAR →The press release announces a concurrent registered direct offering of 1,281,646 ADSs (384.5 million ordinary shares) at US$3.16 per ADS raising approximately US$4.1 million, plus unregistered warrants and an Australian private placement and share purchase plan raising up to A$12.7 million (US$8.9 million). This is a material dilutive equity issuance totaling approximately US$12.9 million in gross proceeds, typical of capital-raising activity by clinical-stage biopharmaceutical companies and clearly material to investors assessing ownership dilution and cash position.
View raw filing on EDGAR →The 6-K discloses entry into a Securities Purchase Agreement on July 23, 2026 for a registered direct offering of 300,000 Class A Ordinary Shares and pre-funded warrants to purchase 4,245,455 additional Class A Ordinary Shares at $1.10 per share (plus $0.001 exercise price for warrants). The offering closed July 24, 2026, raising approximately $4.5 million in net proceeds. This is a dilutive equity issuance that would materially affect shareholder ownership and is a classic capital-raising event requiring disclosure under Item 3.02 equivalent for foreign issuers.
View raw filing on EDGAR →This is a Securities Purchase Agreement dated July 20, 2026, in which Magic Empire Global Limited agrees to issue and sell Class A ordinary shares for an aggregate purchase price of US$5,000,000 to non-U.S. persons under Regulation S. The agreement specifies issuance of shares at US$0.25 per share (21.46% of the prior trading day's closing price), representing a material private placement of equity securities. This is a classic dilutive issuance under Regulation S, a private placement to foreign investors that would materially affect capitalization and shareholder interests.
View raw filing on EDGAR →The filing discloses conversion of a $703,385 loan (principal plus accrued interest) into 146,539 shares of common stock at $4.80 per share under a Loan Conversion Agreement. Item 3.02 explicitly confirms this is an unregistered sale of equity securities issued in reliance on Regulation S. This is a dilutive issuance that increases share count and would materially affect existing shareholders' ownership percentages.
View raw filing on EDGAR →The filing discloses an Exchange Agreement dated July 22, 2026, under which an investor may exchange a $900,000 promissory note (the "Partitioned Note") for shares of common stock at a price determined by recent Nasdaq closing prices. This is a classic convertible debt instrument with an embedded equity conversion feature, structured as an unregistered private placement under Section 4(a)(2) and Section 3(a)(9) of the Securities Act. The disclosure explicitly addresses Item 3.02 (Unregistered Sales of Equity Securities), confirming the dilutive equity issuance component. The beneficial ownership limitation (9.99%) and the mechanics of tranched issuance are typical of dilutive equity raises by smaller public companies.
View raw filing on EDGAR →The filing discloses entry into an amendment to an equity distribution agreement that removes the fixed aggregate dollar limitation on sales, allowing future offers and sales of Common Stock to be limited solely by the amount registered under the effective registration statement. This is a material dilutive issuance under Item 1.01, as it establishes an at-the-market (ATM) or continuous offering program with no cap, creating significant potential dilution to existing shareholders.
View raw filing on EDGAR →Ocean Power Technologies entered into an at-the-market (ATM) offering agreement with H.C. Wainwright & Co. on July 27, 2026, authorizing the sale of up to $20 million in common stock. This is a classic dilutive equity issuance disclosed under Item 1.01 (Entry into a Material Definitive Agreement). ATM offerings are a primary capital-raising mechanism for small- and mid-cap companies and materially affect existing shareholders through dilution.
View raw filing on EDGAR →The filing discloses a Series A Convertible Preferred Stock issuance to LU2 Holdings LLC (Item 1.01, referenced in Items 2.03 and 3.02), accompanied by common stock purchase warrants and a registration rights agreement. While Item 1.02 addresses termination of an ATM agreement, the substantive material event is the creation of convertible preferred equity and warrants—a dilutive capital raise typical of small-cap financing. The exhibits confirm a Securities Purchase Agreement dated July 21, 2026, and warrant issuances, signaling a significant equity financing transaction that would materially affect shareholders.
View raw filing on EDGAR →Polar Power entered into a Committed Equity Facility (CEF) with Roth Principal Investments allowing the Company to sell up to $25 million of newly issued common stock at the Company's discretion over 36 months. The filing explicitly states that "sales of common stock under the facility, if any, are expected to be made at prices based on the prevailing market price" and "such sales...may be dilutive to the Company's existing stockholders." This is a classic at-the-market (ATM) or similar equity facility arrangement that creates a dilutive issuance mechanism.
View raw filing on EDGAR →HPS Corporate Capital Solutions Fund disclosed an unregistered sale of approximately $9.79 million in common shares of beneficial interest across Class I and Class D shares to accredited investors and non-U.S. persons, pursuant to subscription agreements and exempt under Section 4(a)(2) and Regulation D/S.
View raw filing on EDGAR →The filing discloses an unregistered private placement of 217,193 shares of Series A Convertible Preferred Stock under Rule 506(b) of Regulation D, generating $2,137,000 in aggregate proceeds during July 14–26, 2026. This is a classic dilutive equity issuance to accredited investors exempt from registration, with 12.8 million shares of the preferred stock now outstanding. The convertible nature and substantial capital raise make this material to investors assessing the registrant's capital structure and ownership dilution.
View raw filing on EDGAR →The filing discloses multiple unregistered sales of equity securities under Section 4(a)(2) of the Securities Act, including 111,981 Class I shares issued to the Adviser as management fees ($1,160,684), 6,840 Class I shares to a feeder vehicle ($71,975), 124,965 Class I shares to Brookfield and affiliates ($1,295,263), and 19,370 Class E shares to Brookfield and affiliates ($200,599). These private placements and reinvestment plan issuances are dilutive to existing shareholders and material to investor assessment of capital structure and ownership.
View raw filing on EDGAR →The Fund entered into Amendment No. 3 to a sales agreement authorizing the offer and sale of up to 22,000,000 shares of common stock through an at-the-market offering, materially expanding its capacity to raise capital through equity issuance.
View raw filing on EDGAR →Vivakor converted approximately $2.25 million in principal from convertible notes into approximately 2.45 million shares of common stock across three separate financing arrangements between July 21–27, 2026, issued without restrictive legends pursuant to Section 4(a)(2) exemptions, representing substantial dilution to existing shareholders.
View raw filing on EDGAR →Lord Abbett Private Credit Fund issued approximately 426,589 common shares for $10.6 million to shareholders pursuant to subscription agreements, relying on Section 4(a)(2) and Regulation D exemptions from Securities Act registration.
View raw filing on EDGAR →The fund completed an unregistered sale of approximately 263,173 common shares for $6.5 million to accredited investors pursuant to subscription agreements, relying on Section 4(a)(2) and Regulation D exemptions.
View raw filing on EDGAR →BlackRock Private Credit Fund issued 676,246.312 Institutional Class Shares for $15,887,460.36 to feeder vehicles in an unregistered sale exempt under Section 4(a)(2) and Regulation S, increasing share count and diluting existing shareholders.
View raw filing on EDGAR →Rubico announced termination of a $30 million equity line of credit with B. Riley Principal Capital II, LLC, under which the Company had sold approximately $27.1 million of common shares. The disclosure centers on the substantial utilization of the equity issuance program ($27.1M of $30M available), which represents a material dilutive capital-raising activity.
View raw filing on EDGAR →VSee Health issued 1 million restricted shares and two promissory notes (totaling $50K–$125K) to settle disputes with a creditor regarding covenant breaches on an existing debt instrument, including failure to file registration statements and transfer agent instructions.
View raw filing on EDGAR →Vista Credit Strategic Lending Corp. completed an unregistered sale of 150,533 shares of Class I and 7,841 shares of Class S common stock for $3.03 million pursuant to subscription agreements, relying on Section 4(a)(2) and Regulations D and S exemptions.
View raw filing on EDGAR →The filing discloses an unregistered sale of 9,457,500 Class A shares and 3,690,759 Class E shares for aggregate consideration of approximately $131.5 million, conducted under Section 4(a)(2) and Regulation D Rule 506. This is a classic private placement of equity securities exempt from registration, which is material to investors as it represents significant dilution and capital raising activity.
View raw filing on EDGAR →MannKind entered into a Securities Purchase Agreement on July 23, 2026, to sell 10,440,838 shares of common stock at $3.89 per share and 2,412,632 pre-funded warrants at $3.88 per warrant in a private placement, raising approximately $50 million in gross proceeds. The unregistered sale under Section 4(a)(2) of the Securities Act represents a dilutive equity issuance, with proceeds intended for general corporate purposes including a $45 million contingent value rights payment triggered by FDA approval of Furoscix ReadyFlow.
View raw filing on EDGAR →PennantPark Private Income Fund completed an unregistered sale of 31,142 common shares for approximately $805,000 to accredited investors pursuant to Section 4(a)(2) and Regulation D.
View raw filing on EDGAR →Interactive Strength exercised Class B Incremental Warrants resulting in the issuance of a $2,000,000 convertible note and 305,810 common stock warrants with favorable conversion terms (110% uplift, alternate conversion at 85% of VWAP in default) and low conversion prices ($3.597 and $5.527 per share), representing a material dilutive capital raise through an unregistered private placement under Section 4(a)(2) and Regulation D.
View raw filing on EDGAR →On July 21, 2026, the Company entered into an exchange agreement whereby existing stockholders exchanged 392,766 shares of common stock for pre-funded warrants to purchase the same number of shares at $0.0001 per share, relying on Section 3(a)(9) exemption. The transaction restructures the capital stack and materially increases potential dilution, particularly given the warrants' minimal exercise price and RTW Investments' significant existing stake of approximately 38% post-Exchange.
View raw filing on EDGAR →Apollo Asset Backed Credit Company LLC completed unregistered sales of equity securities totaling approximately $48.3 million across Series I and Series II share classes to third-party investors as of July 1, 2026, exempt from registration under Section 4(a)(2) and Regulations D and S.
View raw filing on EDGAR →The exhibit announces a concurrent registered direct offering of 1,281,646 ADSs (384.5 million ordinary shares) at US$3.16 per ADS for US$4.1 million gross proceeds, plus unregistered warrants and an Australian private placement and share purchase plan totaling up to A$12.7 million. This is a material dilutive equity issuance to accredited institutional investors under Section 4(a)(2) and Regulation D, with warrants exercisable at US$3.79 per ADS expiring July 31, 2029, and options at A$0.018 per option. The offering is subject to shareholder approval at an extraordinary general meeting scheduled for September 11, 2026.
View raw filing on EDGAR →The 6-K discloses a 1-for-11 reverse stock split effective July 31, 2026, which consolidates 6,132,100 shares into approximately 557,464 shares. While a reverse split itself is a capital structure adjustment rather than a new issuance, the filing also references recent dilutive equity issuances (June 2026 PIPE private placement and June 2026 convertible note) and adjustments to warrant exercise prices, signaling capital-raising activity and shareholder dilution. The reverse split is typically undertaken to address low stock price and maintain listing compliance, often following dilutive financings. The materiality lies in the capital structure change and its implications for existing shareholders.
View raw filing on EDGAR →AMR Resources Acquisition Corp consummated its IPO on July 16, 2026, issuing 26,000,000 units (including 1,000,000 from over-allotment exercise) at $10.00 per unit for $260 million in gross proceeds, plus 707,500 private placement units for $7.075 million. This is a material capital raise through equity issuance. While technically a SPAC IPO (blank-check company), the disclosure centers on the issuance of equity securities and capital raised, which fits the dilutive_issuance category. The alternative classification would be operational_other (as a SPAC formation event), but the primary material event disclosed is the equity capital raise itself.
View raw filing on EDGAR →VivoSim Labs closed a private placement on July 17, 2026, issuing pre-funded warrants and common warrants to purchase approximately 4.7 million shares of common stock for gross proceeds of $4.0 million.
View raw filing on EDGAR →The press release announces a registered direct offering of 4.5 million units (each consisting of one Class A ordinary share and one common warrant) at $2.00 per unit, generating approximately $9 million in gross proceeds. This is a classic dilutive equity issuance to institutional investors under a shelf registration statement (Form F-3), materially diluting existing shareholders and raising capital through the sale of registered securities.
View raw filing on EDGAR →The 6-K discloses a private placement (PIPE transaction) in which INLIF Limited issued 40,000 Class B ordinary shares to Kerui Enterprise Limited at $2.58 per share for $103,200 in gross proceeds on July 22, 2026. The shares were issued pursuant to Section 4(a)(2) of the Securities Act and Regulation S, explicitly unregistered. This is a classic dilutive equity issuance that would materially affect a reasonable investor's assessment of ownership dilution and capital structure.
View raw filing on EDGAR →Ondas Inc. completed an unregistered sale of equity securities in a private placement exempt from registration under Regulation D. The issuance is material to investors as it affects ownership dilution and the company's capital structure.
View raw filing on EDGAR →Pacific Booker announces the closing of a non-brokered private placement raising $4,000,001.90 through issuance of 1,860,466 units (each comprising one common share and one warrant). This is a material unregistered equity issuance typical of small-cap mining companies raising capital; the proceeds are substantial relative to the company's likely market cap, and the dilution to existing shareholders is significant. A director participated in the placement, further confirming its materiality.
View raw filing on EDGAR →ARMOUR entered into Amendment No. 8 to its Equity Sales Agreement on July 24, 2026, increasing the number of shares available for issuance under an at-the-market offering program by 25,000,000 shares, bringing the total to 25,544,352 shares available for sale through multiple sales agents.
View raw filing on EDGAR →The filing discloses an unregistered sale of 416,954.313 shares of common stock at $9.85 per share for an aggregate offering price of $4,107,000, conducted pursuant to subscription agreements and exempt under Section 4(a)(2) and Regulation D. This is a classic private placement that dilutes existing shareholders and raises material capital for the company.
View raw filing on EDGAR →LGL Group completed a transferable subscription rights offering that resulted in the issuance of 6,062,714 shares of common stock, raising approximately $41.8 million in gross proceeds. This represents a 92.6% subscription rate and increases outstanding shares from approximately 6.5 million to 12.6 million—a material dilution to existing shareholders. The filing discloses the completion of this equity issuance with specific share counts and pro forma balance sheet impacts, which is characteristic of a dilutive equity issuance event.
View raw filing on EDGAR →The filing discloses multiple unregistered equity issuances totaling approximately $789,017 in balance-sheet improvement, including a debt-to-equity conversion of $53,150 (Item 3.02), warrant exercises generating $310,822.90 in proceeds, and conversion of deferred compensation obligations into 20,754 shares. These transactions represent dilutive equity issuances relying on Section 4(a)(2) exemptions, characteristic of private placements and capital raises at small-cap issuers.
View raw filing on EDGAR →Digital Brands Group entered into a Securities Purchase Agreement on July 23, 2026, to issue a $3.529 million convertible promissory note and an Equity Line of Credit (ELOC) facility for up to $100 million in common stock sales. The convertible note is convertible into common stock at 90% of the lowest closing price during a five-day period, and the ELOC grants the purchaser the right to purchase up to $100 million of common stock at 95% of the lowest daily VWAP, both subject to a 19.99% beneficial ownership cap. This represents a significant dilutive equity issuance with substantial downside pricing mechanisms and a multi-year commitment period, materially affecting shareholder equity and voting power.
View raw filing on EDGAR →The 6-K discloses the closing of the first tranche of a private placement involving issuance of unsecured promissory notes (US$10M principal), common warrants to purchase 29.1M ordinary shares, pre-funded warrants to purchase 1.1M ordinary shares, and 676,205 ordinary shares, with US$2M funded at closing. This is a classic dilutive equity issuance with warrant coverage that would materially affect existing shareholders' ownership and voting power, and the concurrent equity purchase agreement permits up to US$100M in additional ordinary shares or pre-funded warrants.
View raw filing on EDGAR →The filing discloses a settlement agreement under which Algorhythm will issue up to 5,000,000 shares of common stock to Continuation Capital, Inc. to settle $1,928,014 in liabilities. This is an unregistered private placement exempt under Section 3(a)(10) of the Securities Act, representing a dilutive equity issuance to settle debt. While Item 5.02 also addresses executive compensation amendments, the principal material event is the equity issuance to resolve outstanding liabilities.
View raw filing on EDGAR →INVO Fertility entered into an Any Market Purchase Agreement with Alumni Capital LP granting the investor the right to purchase up to $15 million (potentially $50 million) of common stock at the Company's discretion. The agreement represents a dilutive equity line of credit arrangement, with shareholder approval obtained for inducement warrants (up to 1,893,492 shares) and future equity financing at below-market prices (up to 20% dilution), supported by an increase in authorized shares from 50 million to 250 million.
View raw filing on EDGAR →Essential Properties Realty Trust entered into an ATM (at-the-market) equity offering sales agreement on July 24, 2026, providing for the offer and sale of up to $750.0 million in common stock through multiple agents. The filing explicitly describes the mechanics of an at-the-market offering under Rule 415 of the Securities Act, including forward sale agreements with financial institutions. This is a material dilutive issuance of equity securities that would affect a reasonable investor's assessment of share dilution and the company's capital structure.
View raw filing on EDGAR →Stark Focus Group entered into a material definitive agreement for an unregistered private placement of 8.4 million shares (4.2 million to each of two investors) for $400,000 total ($200,000 per investor), representing 45.78% aggregate dilution to existing shareholders under Section 4(a)(2) of the Securities Act.
View raw filing on EDGAR →A reverse stock split (1-for-5) is a capital structure change that affects all shareholders' holdings proportionally. While reverse splits are often associated with financial distress or delisting risk mitigation, this disclosure focuses on the mechanical amendment to the Articles of Incorporation and the automatic combination of shares. The event is material to investors as it affects share count and potentially signals underlying financial or listing concerns, but the taxonomy lacks a precise fit—it is neither a dilutive issuance (which involves new equity creation) nor a governance amendment (which would be routine). This is best classified as a capital structure event with material implications, though the confidence is low due to the mismatch between the event's nature and available categories.
View raw filing on EDGAR →The filing discloses an unregistered sale of equity securities totaling approximately $239 million across three share classes (Class I-Series 1, Class S, and Class D shares) on July 1, 2026, exempt under Section 4(a)(2) and Regulations D and S. This is a classic dilutive private placement. The materiality is underscored by the substantial aggregate consideration and the disclosure that the company has raised approximately $7.5 billion cumulatively since inception through such continuous private offerings.
View raw filing on EDGAR →